HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takaya Suzuki Selected Research

exiguolide

6/2013Total synthesis and biological evaluation of (-)-exiguolide analogues: importance of the macrocyclic backbone.
2/2011Total synthesis and biological assessment of (-)-exiguolide and analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takaya Suzuki Research Topics

Disease

4Chronic Obstructive Pulmonary Disease (COPD)
03/2014 - 08/2010
3Neoplasms (Cancer)
02/2022 - 02/2011
2Infections
07/2022 - 08/2010
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2015 - 02/2012
2Fibrosis (Cirrhosis)
09/2013 - 02/2012
2Large Cell Carcinoma
06/2013 - 02/2011
2Adenocarcinoma of Lung
06/2013 - 02/2011
1Pleural Effusion (Pleural Effusions)
12/2021
1Pleurisy (Pleuritis)
12/2021
1Acute Kidney Injury (Acute Renal Failure)
06/2020
1Critical Illness (Critically Ill)
06/2020
1Lung Diseases (Lung Disease)
01/2018
1Idiopathic Pulmonary Fibrosis
09/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
02/2012
1Acute Lung Injury
02/2012
1Lung Injury
07/2011
1Virus Diseases (Viral Diseases)
08/2010
1Common Cold
08/2010
1Human Influenza (Influenza)
08/2010

Drug/Important Bio-Agent (IBA)

2Biological ProductsIBA
01/2018 - 02/2011
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2015 - 09/2013
2E-SelectinIBA
03/2014 - 12/2012
2exiguolideIBA
06/2013 - 02/2011
1elbasvirIBA
07/2022
1sofosbuvir drug combination ledipasvirIBA
07/2022
1grazoprevirIBA
07/2022
1glecaprevir and pibrentasvirIBA
07/2022
1Immune Checkpoint InhibitorsIBA
02/2022
1Anti-Bacterial Agents (Antibiotics)IBA
12/2021
1Messenger RNA (mRNA)IBA
01/2015
1Histone Deacetylase InhibitorsIBA
01/2015
1Protein CIBA
01/2015
1theasinensin AIBA
01/2015
1Surface-Active Agents (Surfactants)IBA
01/2015
1GoldIBA
03/2014
1Transforming Growth Factor beta (TGF-beta)IBA
09/2013
1MicroRNAs (MicroRNA)IBA
09/2013
1GemcitabineFDA Link
01/2013
1Carboplatin (JM8)FDA LinkGeneric
01/2013
1cadherin 5IBA
12/2012
1Biomarkers (Surrogate Marker)IBA
12/2012
1Secretory Proteinase Inhibitory ProteinsIBA
02/2012
1Leukocyte Elastase (Neutrophil Elastase)IBA
02/2012
1InterferonsIBA
01/2012
1LipopolysaccharidesIBA
07/2011
1EndotoxinsIBA
07/2011
1CXCR4 Receptors (CXCR4 Receptor)IBA
07/2011
1Expectorants (Mucolytics)IBA
08/2010
1CytokinesIBA
08/2010
1Interleukin-6 (Interleukin 6)IBA
08/2010
1RNA (Ribonucleic Acid)IBA
08/2010
1N-Acetylneuraminic Acid (Sialic Acid)IBA
08/2010
1NF-kappa B (NF-kB)IBA
08/2010

Therapy/Procedure

1Thoracotomy
01/2021
1Continuous Renal Replacement Therapy
06/2020